Study on Treatment of Peri-implantitis with Soft Tissue Augmentation Initiated
A clinical trial is comparing reconstructive treatment methods for peri-implantitis, evaluating outcomes with and without soft tissue augmentation.
Phase III
Dental / Peri-implantitis
Status
Initiated
Sponsor
Peri-implantitis
Signal Score
6.8
Signal assessment
Signal strength
moderate
Confidence level
moderate
Why it matters
This clinical trial is pivotal in determining the effectiveness of soft tissue augmentation in treating peri-implantitis, which could reshape treatment protocols in dental implantology. The outcomes may influence product development and market positioning for companies involved in dental grafting materials.
Recommended action
Humanexa recommends Monitor.
Analysis
Key milestones include interim results on patient-reported outcomes and defect resolution metrics.
Related companies & assets
Companies
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.